1260848-51-8

Basic information

• Product Name: Methyl 4-aMino-2-Methyl-5-nitrobenzoate
• Synonyms: Methyl 4-aMino-2-Methyl-5-nitrobenzoate
• CAS NO: 1260848-51-8
• Molecular Formula: C₉H₁₀N₂O₄
• Molecular Weight: 210.1867
• Mol File: 1260848-51-8.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 403.7±40.0 °C(Predicted)
• Appearance: /
• Density: 1.332±0.06 g/cm3(Predicted)
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• PKA: -2.34±0.25(Predicted)
• CAS DataBase Reference: Methyl 4-aMino-2-Methyl-5-nitrobenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 4-aMino-2-Methyl-5-nitrobenzoate(1260848-51-8)
• EPA Substance Registry System: Methyl 4-aMino-2-Methyl-5-nitrobenzoate(1260848-51-8)

Safety Data

• Hazardous Substances Data: 1260848-51-8(Hazardous Substances Data)

Usage

General Description

Methyl 4-amino-2-methyl-5-nitrobenzoate is a chemical compound with the molecular formula C9H10N2O4. It is commonly used in organic synthesis and research as an intermediate or building block for the production of various pharmaceuticals and agrochemicals. Methyl 4-aMino-2-Methyl-5-nitrobenzoate is a yellow crystalline powder with a molecular weight of 198.19 g/mol. It is important to handle this chemical with caution as it may be harmful if swallowed, inhaled, or comes in contact with skin. Additionally, it may cause irritation to the eyes, skin, and respiratory system. Therefore, proper safety precautions and handling procedures should be followed when working with this chemical.

Upstream product

• 1163287-01-1 methyl 4-fluoro- 2-methyl-5-nitrobenzoate 
• 67-56-1 methanol 
• 103204-69-9 4-acetylamino-2-methylbenzoic acid 
• 321-21-1 4-fluoro-2-methylbenzoic acid 
• 174403-69-1 4-fluoro-2-methyl benzoic acid methyl ester 

Downstream Products

• 1243163-72-5 methyl 4,5-diamino-2-methyl benzoate 

Relevant articles and documents

INDAZOLES AS LRRK2 INHIBITORS

The present invention is directed to indazole compounds which are inhibitors of LRRK2 and are useful in the treatment of CNS disorders.

BENZIMIDAZOL-2-AMINES AS MIDH1 INHIBITORS

The present invention relates to benzimidazol-2-amines of general formula (I), in which R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and R12 are as defined herein, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of neoplasms, as a sole agent or in combination with other active ingredients.